Ashish Shukla, PhD is an independent consultant to the biopharmaceutical industry with over six years of experience in market research and competitive intelligence. His consultancy firm Oncofocus Solutions caters to the primary and secondary research needs of biopharmaceutical companies looking for business solutions in the oncology domain. The firm's guiding principle is "to become a decision support partner by providing framework driven research support and actionable insights".
Ashish holds a PhD from the German Cancer Research Centre, Heidelberg, Germany and has over seven years of research experience in molecular biology. He has authorship in eight peer-reviewed research papers.
« People « Contributors
Articles by Ashish Shukla:
Product review of PharmaCircle Business Class Elite (value - help & training; competitors; development; pricing)Wednesday, 26th September 2018
In the final part of our product review of PharmaCircle Business Class Elite (BCE) we look at the help and training available. The company considers one-to-one customer support its top priority with a team of experts to provide the required support. Its competitors, who include Thomson Reuters' Cortellis, Informa's Pharmaprojects, and Springer Nature's AdisInsight, along with pricing and development plans, including the refinement of its proprietary search technology.
Note: Full review (PDF) at https://web.jinfo.com/go/sub/report/3058
Product review of PharmaCircle Business Class Elite (technology - search & user interface; outputs & alerts; administration)Tuesday, 25th September 2018
The third part of our product review of PharmaCircle Business Class Elite (BCE) for drug, biologics, product development and market landscape. We explore the product's technology, including its proprietary search platform and interface that provides access to apps, outputs and alerts and charting options for areas from patents to labels and development timelines.
Product review of PharmaCircle Business Class Elite (sources - content & coverage)Monday, 24th September 2018
Part two of our product review of PharmaCircle Business Class Elite (BCE) looks at the range of key information sources tracked by the product's analysts and available via its 11 modules and 6 apps, including geographic coverage and languages available.
Product review of PharmaCircle Business Class Elite (key advantages; introduction; contact details)Friday, 21st September 2018
PharmaCircle Business Class Elite (BCE) is an online platform offering continuously updated information on products and pipeline programmes, public and private companies, and global clinical trial records. In this first part of our product review, we take a closer look at the company and product, its users, who include the top 20 pharmaceutical companies, as well as its key features and value.
CMOCRO - Supporting the Search for Pharmaceutical PartnersWednesday, 29th April 2015
The CMOCRO site is a global repository of pharmaceutical suppliers and aims to support its users by providing relevant information regarding the suitability of prospective partners. Reviewer Ashish Shukla highlights a couple of his favourite features of this free-to-use site and what it offers organisations or individuals looking for partnering support.
Mini Review of CMOCRO from PharmaCircleTuesday, 28th April 2015
Ashish Shukla reviews the quick and easy CMOCRO platform from PharmaCircle, an open-access, global database of pharmaceutical suppliers. Particularly impressive is its intuitive interface and the powerful "Compare and Contrast" feature for pharmaceutical companies.
AdisInsight Offers Single Point of Access to Entire Drug LifecycleThursday, 19th March 2015
AdisInsight is a new platform developed by Springer that offers quick and easy search into more than 210,000 scientifically curated records. The platform allows access to well-structured information pertaining to the entire drug lifecycle, thus, rendering the platform as a "one stop solution" for organisations working across the healthcare spectrum.
Product Review of AdisInsight (Customer Support; FreePint's View)Friday, 13th March 2015
In the final part of his product review of Springer's new AdisInsight drug information platform, Ashish Shukla looks at customer support and gives an overview of its strengths as a single point of access platform. He analyses the overall value that the product offers to those seeking a one-stop solution on the entire drug lifecycle, from profiles of drugs in development, insights into the trials being performed to advance these drugs through regulatory pathways, to safety reports associated with a drug, and any deals undertaken by the organisations involved.
Note: Full review (PDF) at https://web.jinfo.com/go/sub/report/2468
Product Review of AdisInsight (Safety - Value Proposition and Competitor Landscape)Thursday, 12th March 2015
In Part 8 of his product review of Springer's new AdisInsight drug information platform, Ashish Shukla looks at the value of the coverage of its extensive safety records database, including the particularly useful Narrative Summaries. He comments on its safety strengths and usefulness in identifying emerging safety issues. Competitors include Cortellis, Medi-Span, FAERS, and adrreports.eu.
Product Review of AdisInsight (Drugs - Value Proposition and Competitor Landscape)Monday, 9th March 2015
In Part 7 of his product review of Springer's new AdisInsight drug information platform, Ashish Shukla looks at the value of the coverage of the drugs R&D database, including how it can demonstrate commercial opportunities. This comprehensive repository contains scientific profiles of more than 30,000 drugs. Competitors include Cortelli's, Pharmaprojects and Medtrack.
Product Review of AdisInsight (Trials - Value and Competitor Landscape)Friday, 27th February 2015
In part 6 of his product review of Springer's new AdisInsight drug information platform, Ashish Shukla looks at the value of the coverage of key clinical trials, one of the three databases brought together under a single access point.
Product Review of AdisInsight (Technology)Monday, 23rd February 2015
In part 5 of his product review, Ashish Shukla looks at the technology behind Springer's new AdisInsight drug information platform. He looks at the accessibility of Adis's newly-created single access point for its three databases, including areas such as search functionality and outputs.
Product Review of AdisInsight (Safety - Content and Coverage)Tuesday, 17th February 2015
Ashish Shukla looks at the AdisInsight platform's coverage of adverse drug reaction reports, safety studies and regulatory news in part 4 of his nine-part product review of Springer's new database of scientifically curated drug information, looking at its search results, filtering capacity and expert narrative summaries & comment.
Product Review of AdisInsight (Drugs - Content and Coverage)Tuesday, 10th February 2015
In Part 3 of his nine-part product review of AdisInsight, Springer's new database of scientifically curated drug information, Ashish Shukla looks at its coverage of information on drugs in commercial development worldwide. He gives a detailed assessment of how the platform consistently organises its drug profiles, which are updated daily.
Product Review of AdisInsight (Trials - Content and Coverage)Thursday, 5th February 2015
In Part 2 of his nine-part Product Review of AdisInsight, Springer's new database of scientifically curated drug information, Ashish Shukla looks at coverage of key clinical trials, and search features including the Query Builder function and strong referencing.
Product Review of AdisInsight (Introduction; Contact Details)Tuesday, 3rd February 2015
Ashish Shukla introduces his nine-part product review of AdisInsight, a new endeavour by Springer to bring its three drug information databases together, encompassing profiles of clinical trials, R&D, drug safety studies and regulatory news, written by scientists. Users can find trusted results via a single search.
News in the Pharma LandscapeTuesday, 23rd December 2014
Ashish Shukla outlines the four major categories of information needs in the pharmaceutical industry and debates the value of general news sources vs specialist.
Specialist News Offerings - Pharma SectorWednesday, 10th December 2014
Ashish Shukla considers key categories of pharmaceutical news for companies seeking to develop and successfully commercialise innovative products. He then takes a detailed look at three specialist sources for the STM sector: FirstWord Pharma, Oncology Business Review (OBR) and Pharma & MedTech Business Intelligence.
Niche Data Visualisation Tools - FreePint for BiopharmaFriday, 21st November 2014
Ashish Shukla looks at three recent product reviews and how Cortellis, Innography and Digimind Social perform in terms of allowing information managers to slice and dice data and obtain intuitive visual outputs.
Reports by Ashish Shukla:
Product review of PharmaCircle Business Class Elite (BCE)Friday, 21st September 2018
PharmaCircle Business Class Elite (BCE) is an online resource for professionals in the biopharmaceutical industry. It offers continuously updated and comprehensive content on products and pipeline programmes, public and private companies, and global clinical trial records.
It is used by...
Product Review of AdisInsightWednesday, 18th March 2015
Product review of the AdisInsight platform. Competitors include Cortellis, Medi-Span, Pharmaprojects and Trialtrove but AdisInsight provides a single access point to an impressive volume of scientifically-curated data for the whole drug lifecycle.
Includes an overview...
Document the value chain, and transform the way you think about, manage and report on your product portfolio and your information service contributions to your organisation goals.
Focus on Value Chain
Risk assessment is a required process for a healthy information department. It gauges the ability of your services, team, portfolio and overall value to withstand stress.
Focus on Risk Assessment
Sorry, there seems to be a problem with Webinar and Community listings. Please let us know, by email to email@example.com. Thank you.